Sulforaphane prevents microcystin-LR-induced oxidative damage and apoptosis in BALB/c mice

Toxicology and Applied Pharmacology

Volumn 255, Issue 1, 2011, Pages 9-17

  Sun, Xiaoyun ^a   Mi, Lixin ^b   Liu, Jin ^a   Song, Lirong ^a   Chung, Fung Lung ^b   Gan, Nanqin ^a  

^a INSTITUTE OF HYDROBIOLOGY   (China)

^b GEORGETOWN UNIVERSITY   (United States)

Author keywords

Apoptosis; Microcystin LR (MC LR); NF E2 related factor 2 (Nrf2); Reactive oxygen species (ROS); Sulforaphane (SFN)

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CASPASE 3; CYTOCHROME P450; GLUTATHIONE; MICROCYSTIN LR; SULFORAPHANE; TRANSCRIPTION FACTOR NRF2;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BAGG ALBINO MOUSE; CONTROLLED STUDY; ENZYME ACTIVITY; HISTOPATHOLOGY; INFLAMMATION; LIPID PEROXIDATION; LIVER PROTECTION; LIVER TOXICITY; MALE; MOUSE; NONHUMAN; OXIDATION; OXIDATIVE STRESS;

ANIMALS; APOPTOSIS; CYTOCHROME P-450 CYP2E1; GLUTATHIONE; INFLAMMATION; LIVER; MALE; MICE; MICE, INBRED BALB C; MICROCYSTINS; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; THIOCYANATES; TUMOR NECROSIS FACTOR-ALPHA;

ALGAE; ANIMALIA; MICROCYSTIS; MUS;

EID: 79960841460     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2011.05.011     Document Type: Article

References (40)

1. Bai J., Sui J., Demirjian A., Vollmer C.M., Marasco W., Callery M.P. Predominant Bcl-XL knockdown disables antiapoptotic mechanisms: tumor necrosis factor-related apoptosis-inducing ligand-based triple chemotherapy overcomes chemoresistance in pancreatic cancer cells in vitro. Cancer Res. 2005, 65:2344-2352.
2. Barcelo S., Gardiner J.M., Gescher A., Chipman J.K. CYP2E1-mediated mechanism of anti-genotoxicity of the broccoli constituent sulforaphane. Carcinogenesis 1996, 17:277-282.
3. Blankson H., Grotterød E.M., Seglen P.O. Prevention of toxin-induced cytoskeletal disruption and apoptotic liver cell death by the grapefruit flavonoid, naringin. Cell Death Differ. 2000, 7:739-746.
4. Blydt-Hansen T.D., Katori M., Lassman C., Ke B., Coito A.J., Iyer S., et al. Gene transfer-induced local heme oxygenase-1 overexpression protects rat kidney transplants from ischemia/reperfusion injury. J. Am. Soc. Nephrol. 2003, 14:745-754.
5. Bøe R., Gjertsen B.T., Vintermyr O.K., Houge G., Lanotte M., Døskeland S.O. The protein phosphatase inhibitor okadaic acid induces morphological changes typical of apoptosis in mammalian cells. Exp. Cell Res. 1991, 195:237-246.
6. BouaÏcha N., Maatouk I. Microcystin-LR and nodularin induce intracellular glutathione alteration, reactive oxygen species production and lipid peroxidation in primary cultured rat hepatocytes. Toxicol. Lett. 2004, 148:53-63.
7. Carmichael W.W. The toxins of cyanobacteria. Sci. Am. 1994, 270:78-86.
8. Chawla-Sarker M., Bae S.I., Reu F.J., Jacobs B.S., Lindner D.J., Borden E.C. Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L/TRAIL-induced apoptosis. Cell Death Differ. 2004, 11:915-923.
9. Chen T., Wang Q., Cui J., Yang W., Shi Q., Hua Z., Ji J., Shen P. Induction of apoptosis in mouse liver by microcystin-LR: a combined transcriptomic, proteomic, and simulation strategy. Mol. Cell Proteom. 2005, 4:958-974.
10. Cheung K.L., Kong A.N. Molecular targets of dietary phenethyl isothiocyanate and sulforaphane for cancer chemoprevention. AAPS J. 2010, 12:87-97.
11. Cornblatt B.S., Ye L.X., Dinkova-Kostova A.T., Erb M., Fahey J.W., Singh N.K., et al. Preclinical and clinical evaluation of sulforaphane for chemoprevention in the breast. Carcinogenesis 2007, 28:1485-1490.
12. Esterbauer H., Cheeseman K.H. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonetal. Method Enzymol. 1990, 186:407-421.
13. Fischer W.J., Dietrich D.R. Pathological and biochemical characterization of microcystin-induced hepatopancreas and kidney damage in carp (Cyprinus carpio). Toxicol. Appl. Pharmacol. 2000, 164:73-81.
14. Gan N.Q., Mi L.X., Sun X.Y., Dai G.F., Chung F.L., Song L.R. Sulforaphane protects microcystin-LR-induced toxicity through activation of the Nrf2-mediated defensive response. Toxicol. Appl. Pharmacol. 2010, 247:129-137.
15. Gan N.Q., Sun X.Y., Song L.R. Activation of Nrf2 by microcystin-LR provides advantages for liver cancer cell growth. Chem. Res. Toxicol. 2010, 23:1477-1484.
16. Gehringer M.M., Govender S., Shah M. An investigation of the role of vitamin E in the protection of mice against microcystin toxicity. Environ. Toxicol. 2003, 18:142-148.
17. Guzman R.E., Solter P.F. Hepatic oxidative stress following prolonged sublethal microcystin LR exposure. Toxicol. Pathol. 1999, 27:582-588.
18. Harada K.I., Tsuji K., Watanabe M.F., Kondo F. Stability of microcystins from cyanobacteria - III. Effect of pH and temperature. Phycologia 1996, 35(6 Suppl.):83-88.
19. Heiss E., Herhaus C., Klimo K., Bartsch H., Gerhauser C. Nuclear factor kappa B is a molecular target for sulforaphane-mediated anti-inflammatory mechanisms. J. Biol. Chem. 2001, 276:32008-32015.
20. Herfindal L., Myhren L., Kleppe R., Krakstad C., Selheim F., Jokela J., Sivonen K., Døskeland S.O. Nostocyclopeptide-M1: a potent, nontoxic inhibitor of the hepatocyte drug transporters OATP1B3 and OATP1B1. Mol. Pharm. 2011, 8:360-367.
21. Hermansky S.J., Markin R.S., Fowler E.H., Stohs S.J. Hepatic ultrastructural changes induced by the toxin microcystin-LR in mice. J. Environ. Pathol. Toxicol. Oncol. 1993, 12:101-106.
22. Homma S., Ishii Y., Morishima Y., Yamadori T., Matsuno Y., et al. Nrf2 enhances cell proliferation and resistance to anticancer drugs in human lung cancer. Clin. Cancer Res. 2009, 15:3423-3432.
23. Hooser S.B., Beasley V.R., Basgall E.J., Carmichael W.W., Haschek W.M. Microcystin-LR-induced ultrastructural changes in rats. Vet. Pathol. 1990, 27:9-15.
24. Hu C.L., Gan N.Q., Chen Y.Y., Bi L.J., Zhang X.E., Song L.R. Detection of microcystins in environmental samples using surface plasmon resonance biosensor. Talanta 2009, 80:407-410.
25. Jin C.Y., Moon D.O., Lee J.D., Heo M.S., Choi Y.H., Lee C.M., Park Y.M., Kim G.Y. Sulforaphane sensitizes tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis through downregulation of ERK and Akt in lung adenocarcinoma A549 cells. Carcinogenesis 2007, 28:1058-1066.
26. Juge N., Mithen R.F., Traka M. Molecular basis for chemoprevention by sulforaphane: a comprehensive review. Cell Mol. Life Sci. 2007, 64:1105-1127.
27. Kim H., Kim E.H., Eom Y.W., Kim W.H., Kwon T.K., Lee S.J., Choi K.S. Sulforaphane sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-resistant hepatoma cells to TRAIL-induced apoptosis through reactive oxygen species-mediated up-regulation of DR5. Cancer Res. 2006, 66:1740-1750.
28. Krakstad C., Herfindal L., Gjertsen B.T., Bøe R., Vintermyr O.K., Fladmark K.E., Døskeland S.O. CaM-kinaseII-dependent commitment to microcystin-induced apoptosis is coupled to cell budding, but not to shrinkage or chromatin hypercondensation. Cell Death Differ. 2006, 13:1191-1202.
29. Lin W., Wu R.T., Wu T.Y., Khor T.O., Wang H., Kong A.N. Sulforaphane suppressed LPS-induced inflammation in mouse peritoneal macrophages through Nrf2 dependent pathway. Biochem. Pharmacol. 2008, 76:967-973.
30. Matsushima R.N., Ohta T., Nishiwaki S., Suganuma M., Kohyama K., Ishikawa T., Carmichael W.W., Fujiki H. Liver tumor promotion by the cyanobacterial cyclic peptide toxin microcystin-LR. J. Cancer Res. Clin. Oncol. 1992, 118:420-424.
31. Nong Q.Q., Komatsu M., Izumo K., Indo H.P., Xu B.H., Aoyama K., Majima H.J., et al. Involvement of reactive oxygen species in microcystin-LR-induced cytogenotoxicity. Free. Radic. Res. 2007, 41:1326-1337.
32. Pflugmacher S., Wiegand C., Oberemm A., Beattie K.A., Krause E., Codd G.A., et al. Identification of an enzymatically formed glutathione conjugate of the cyanobacterial hepatotoxin microcystin LR: the first step in detoxification. Biochim. Biophys. Acta 1998, 1425:527-533.
33. Pinho G.L., da Rosa C.M., Maciel F.E., Bianchini A., Yunes J.S., Proença L.A., Monserrat J.M. Antioxidant responses after microcystin exposure in gills of an estuarine crab species pre-treated with vitamin E. Ecotoxicol. Environ. Saf. 2005, 61:361-365.
34. Prieto A.I., Jos A., Pichardo S., Moreno I., Sotomayor M.Á., Moyano R., Blanco A., Cameán A.M. Time-dependent protective efficacy of Trolox (vitamin E analog) against microcystin-induced toxicity in tilapia (Oreochromis niloticus). Environ. Toxicol. 2009, 24:563-579.
35. Takenaka S. Covalent glutathione conjugation to cyanobacterial hepatotoxin microcystin LR by F344 rat cytosolic and microsomal glutathione S-transferases. Environ. Toxicol. Pharmacol. 2001, 9:135-139.
36. Talalay P., Fahey J.W., Healy Z.R., Wehage S.L., Benedict A.L., Min C., Dinkova-Kostova A.T. Sulforaphane mobilizes cellular defenses that protect skin against damage by UV radiation. Proc. Natl. Acad. Sci. U. S. A 2007, 104:17500-17505.
37. Ueno Y., Nagata S., Tsutsumi T., Yu S.Z. Detection of microcystins, a blue-green algal hepatotoxin, in drinking water sample in Haimen and Fusui, endemic areas of primary liver cancer in China, by highly sensitive immunoassay. Carcinogenesis 1996, 17:1317-1321.
38. William O.O., Thomas W.K. Nrf2 signaling: an adaptive response pathway for protection against environmental toxic insults. Mutat. Res. Rev. Mutat. Res. 2008, 659:31-39.
39. Yoshida T., Takeda M., Tsutsumi T., Nagata S., Yoshida F., Maita K., Harada T., Ueno Y. Tumor necrosis factor-α expression and Kupffer cell activation in hepatotoxicity caused by microcystin-LR in mice. J. Toxicol. Pathol. 2001, 14:259-265.
40. Zhang Y., Kensler T.W., Cho C.G., Posner G.H., Talalay P. Anticarcinogenic activities of sulforaphane and structurally related synthetic norbornyl isothiocyanates. Proc. Natl. Acad. Sci. U. S. A 1994, 91:3147-3150.